Correlation
The correlation between EBS and PLTK is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Maximize Your Portfolio’s Potential
Does your portfolio have the optimal asset allocation aligned with your goals? Find it out with our portfolio optimizer
Try portfolio optimization nowEBS vs. PLTK
Compare and contrast key facts about Emergent BioSolutions Inc. (EBS) and Playtika Holding Corp. (PLTK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EBS or PLTK.
Performance
EBS vs. PLTK - Performance Comparison
Key characteristics
EBS:
0.04
PLTK:
-0.93
EBS:
1.25
PLTK:
-1.31
EBS:
1.17
PLTK:
0.83
EBS:
0.27
PLTK:
-0.47
EBS:
0.59
PLTK:
-1.67
EBS:
44.12%
PLTK:
24.81%
EBS:
122.25%
PLTK:
45.95%
EBS:
-98.89%
PLTK:
-87.38%
EBS:
-95.25%
PLTK:
-84.80%
Fundamentals
EBS:
$347.92M
PLTK:
$1.79B
EBS:
-$2.58
PLTK:
$0.38
EBS:
0.36
PLTK:
0.69
EBS:
0.62
PLTK:
0.00
EBS:
$960.00M
PLTK:
$2.60B
EBS:
$303.40M
PLTK:
$1.89B
EBS:
$106.30M
PLTK:
$513.60M
Returns By Period
In the year-to-date period, EBS achieves a -32.95% return, which is significantly lower than PLTK's -28.81% return.
EBS
-32.95%
24.71%
-31.00%
4.91%
-41.63%
-40.34%
-13.89%
PLTK
-28.81%
-11.21%
-41.51%
-42.47%
-28.87%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EBS vs. PLTK — Risk-Adjusted Performance Rank
EBS
PLTK
EBS vs. PLTK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and Playtika Holding Corp. (PLTK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EBS vs. PLTK - Dividend Comparison
EBS has not paid dividends to shareholders, while PLTK's dividend yield for the trailing twelve months is around 8.28%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
EBS Emergent BioSolutions Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.65% |
PLTK Playtika Holding Corp. | 8.28% | 5.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
EBS vs. PLTK - Drawdown Comparison
The maximum EBS drawdown since its inception was -98.89%, which is greater than PLTK's maximum drawdown of -87.38%. Use the drawdown chart below to compare losses from any high point for EBS and PLTK.
Volatility
EBS vs. PLTK - Volatility Comparison
Emergent BioSolutions Inc. (EBS) has a higher volatility of 39.63% compared to Playtika Holding Corp. (PLTK) at 15.17%. This indicates that EBS's price experiences larger fluctuations and is considered to be riskier than PLTK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
EBS vs. PLTK - Financials Comparison
This section allows you to compare key financial metrics between Emergent BioSolutions Inc. and Playtika Holding Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EBS vs. PLTK - Profitability Comparison
EBS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Emergent BioSolutions Inc. reported a gross profit of 133.70M and revenue of 222.20M. Therefore, the gross margin over that period was 60.2%.
PLTK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Playtika Holding Corp. reported a gross profit of 508.60M and revenue of 706.00M. Therefore, the gross margin over that period was 72.0%.
EBS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Emergent BioSolutions Inc. reported an operating income of 49.90M and revenue of 222.20M, resulting in an operating margin of 22.5%.
PLTK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Playtika Holding Corp. reported an operating income of 67.80M and revenue of 706.00M, resulting in an operating margin of 9.6%.
EBS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Emergent BioSolutions Inc. reported a net income of 68.00M and revenue of 222.20M, resulting in a net margin of 30.6%.
PLTK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Playtika Holding Corp. reported a net income of 30.60M and revenue of 706.00M, resulting in a net margin of 4.3%.
Competitive Comparison
See how gross margin, operating margin, and net margin compare for the largest companies in the Drug Manufacturers - Specialty & Generic industry.
| Symbol | Name | Market Cap | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| 000105.KS | Yuhan Corp Preferred | 7.79T | 30.2% | 30.2% | 1.8% |
| 000100.KS | Yuhan Corporation | 7.79T | 30.2% | 30.2% | 1.8% |
| SUNPHARMA.NS | Sun Pharmaceutical Industries Limited | 4.00T | 79.6% | 26.5% | 21.6% |
| 128940.KS | Hanmi Pharm Co Ltd | 3.86T | 54.6% | 54.6% | 10.9% |
| 069620.KS | Daewoong Pharma | 1.94T | 51.4% | 51.4% | 6.1% |
| DIVISLAB.NS | Divi's Laboratories Limited | 1.73T | 62.1% | 30.1% | 25.6% |
| 006280.KS | Green Cross Corp | 1.46T | 29.4% | 29.4% | 7.7% |
| 009420.KS | Hanall Biopharma | 1.31T | 53.1% | 53.1% | -0.6% |
| 185750.KS | Chong Kun Dang Pharmaceutical | 1.13T | 30.8% | 30.8% | 2.9% |
| 003090.KS | Daewoong | 1.12T | 100.0% | 100.0% | 5.4% |
EBS vs. PLTK - Valuation Comparison
PLTK - PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PLTK, comparing it with other companies in the Electronic Gaming & Multimedia industry. Currently, PLTK has a P/E ratio of 12.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
EBS - PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for EBS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. EBS currently has a PEG ratio of 1.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
EBS - PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for EBS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, EBS has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PLTK - PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PLTK relative to other companies in the Electronic Gaming & Multimedia industry. Currently, PLTK has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
EBS - PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for EBS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, EBS has a P/B value of 0.6. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
PLTK - PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PLTK in comparison with other companies in the Electronic Gaming & Multimedia industry. Currently, PLTK has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
User Portfolios with EBS or PLTK
Recent discussions
Risk adjusted performance indexes
Hello:
Over what period are risk adjusted performance indexes calculated in "Stock Comparison" tool?
Thanks
Marcus Crahan
Risk adjusted performance
The sortino calculation generates a ratio per day over the specified period.
Does this mean that the MAR is the minimum acceptable return per day (365)?
Marcus Crahan
New Tickers, Please: SCHN, SMBS, and HIMU
Karl Restall